133 related articles for article (PubMed ID: 2955674)
1. Clodronate treatment in patients with malignancy-associated hypercalcemia.
Rastad J; Benson L; Johansson H; Knuutila M; Pettersson B; Wallfelt C; Akerström G; Ljunghall S
Acta Med Scand; 1987; 221(5):489-94. PubMed ID: 2955674
[TBL] [Abstract][Full Text] [Related]
2. Treatment with clodronate in patients with hypercalcemia secondary to malignancy.
Lind L; Wengle B; Ljunghall S
Ups J Med Sci; 1987; 92(3):259-63. PubMed ID: 2966487
[TBL] [Abstract][Full Text] [Related]
3. The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy.
Adami S; Bolzicco GP; Rizzo A; Salvagno G; Bertoldo F; Rossini M; Suppi R; Lo Cascio V
Bone Miner; 1987 Aug; 2(5):395-404. PubMed ID: 2975514
[TBL] [Abstract][Full Text] [Related]
4. Use of clodronate and calcitonin in hypercalcemia due to malignancy.
Ljunghall S
Recent Results Cancer Res; 1989; 116():40-5. PubMed ID: 2527399
[TBL] [Abstract][Full Text] [Related]
5. Parenteral diphosphonates for treating malignant hypercalcemia.
Jung A; van Ouwenaller C; Chantraine A; Courvoisier B
Cancer; 1981 Oct; 48(8):1922-5. PubMed ID: 6456809
[TBL] [Abstract][Full Text] [Related]
6. Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.
O'Rourke NP; McCloskey EV; Vasikaran S; Eyres K; Fern D; Kanis JA
Br J Cancer; 1993 Mar; 67(3):560-3. PubMed ID: 8439504
[TBL] [Abstract][Full Text] [Related]
7. Clodronate as a single-dose intravenous infusion effectively provides short-term correction of malignant hypercalcemia.
Atula ST; Tähtelä RK; Nevalainen JI; Pylkkänen LH
Acta Oncol; 2003; 42(7):735-40. PubMed ID: 14690159
[TBL] [Abstract][Full Text] [Related]
8. [[Clodronate therapy of hypercalcemia caused by hyperparathyroidism].
Hoffmeyer P; Groebli Y; Spiliopoulos A; Jung A
Schweiz Med Wochenschr; 1982 Jan; 112(4):118-20. PubMed ID: 6461066
[TBL] [Abstract][Full Text] [Related]
9. Safety of subcutaneous clodronate and efficacy in hypercalcemia of malignancy: a novel route of administration.
Roemer-Bécuwe C; Vigano A; Romano F; Neumann C; Hanson J; Quan HK; Walker P
J Pain Symptom Manage; 2003 Sep; 26(3):843-8. PubMed ID: 12967733
[TBL] [Abstract][Full Text] [Related]
10. Treatment of tumor hypercalcemia with clodronate.
Ziegler R; Scharla SH
Recent Results Cancer Res; 1989; 116():46-53. PubMed ID: 2527400
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol].
Scharla SH; Minne HW; Sattar P; Mende U; Blind E; Schmidt-Gayk H; Wüster C; Ho T; Ziegler R
Dtsch Med Wochenschr; 1987 Jul; 112(28-29):1121-5. PubMed ID: 2956079
[TBL] [Abstract][Full Text] [Related]
12. Clodronate in hypercalcemia of malignancy.
Bonjour JP; Rizzoli R
Calcif Tissue Int; 1990; 46 Suppl():S20-5. PubMed ID: 2137362
[TBL] [Abstract][Full Text] [Related]
13. Clodronate. A randomized study in the treatment of cancer-related hypercalcemia.
Witte RS; Koeller J; Davis TE; Benson AB; Durie BG; Lipton A; Stock JL; Citrin DL; Jacobs TP
Arch Intern Med; 1987 May; 147(5):937-9. PubMed ID: 2953318
[TBL] [Abstract][Full Text] [Related]
14. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
Plosker GL; Goa KL
Drugs; 1994 Jun; 47(6):945-82. PubMed ID: 7521833
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of calcitonin and clodronate in hypercalcaemia.
Ljunghall S; Rastad J; Akerström G
Bone; 1987; 8 Suppl 1():S79-83. PubMed ID: 2961359
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pharmacokinetics of clodronate after single and repeated doses.
Ylitalo P; Holli K; Mönkkönen J; Elo HA; Juhakoski A; Liukko-Sipi S; Ylitalo R
Int J Clin Pharmacol Ther; 1999 Jun; 37(6):294-300. PubMed ID: 10395121
[TBL] [Abstract][Full Text] [Related]
17. Treatment of malignant hypercalcaemia with clodronate.
Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
[TBL] [Abstract][Full Text] [Related]
18. Use of dichloromethylene diphosphonate in metastatic bone disease.
Jung A; Chantraine A; Donath A; van Ouwenaller C; Turnill D; Mermillod B; Kitler ME
N Engl J Med; 1983 Jun; 308(25):1499-501. PubMed ID: 6222257
[TBL] [Abstract][Full Text] [Related]
19. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
Purohit OP; Radstone CR; Anthony C; Kanis JA; Coleman RE
Br J Cancer; 1995 Nov; 72(5):1289-93. PubMed ID: 7577484
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications.
Clemens MR; Fessele K; Heim ME
Ann Hematol; 1993 Mar; 66(3):141-6. PubMed ID: 8471660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
